HHS and MedPAC Reports Encourage Significant Changes to Part B Drug Payment
The Academy is monitoring congressional reaction to these reports given that the recommendations would impact ophthalmologists.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.